BR112014009266A2 - processo para a preparação de ácidos isoxazolil-metóxi-nicotínicos - Google Patents

processo para a preparação de ácidos isoxazolil-metóxi-nicotínicos

Info

Publication number
BR112014009266A2
BR112014009266A2 BR112014009266A BR112014009266A BR112014009266A2 BR 112014009266 A2 BR112014009266 A2 BR 112014009266A2 BR 112014009266 A BR112014009266 A BR 112014009266A BR 112014009266 A BR112014009266 A BR 112014009266A BR 112014009266 A2 BR112014009266 A2 BR 112014009266A2
Authority
BR
Brazil
Prior art keywords
preparation
isoxazolyl
nicotinic acids
methoxy nicotinic
methoxy
Prior art date
Application number
BR112014009266A
Other languages
English (en)
Other versions
BR112014009266B1 (pt
BR112014009266A8 (pt
Inventor
Thomas Andrew
Iding Hans
Dott Pascal
Waldmeier Pius
Hildbrand Stefan
Paul Hanlon Steven
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112014009266A2 publication Critical patent/BR112014009266A2/pt
Publication of BR112014009266A8 publication Critical patent/BR112014009266A8/pt
Publication of BR112014009266B1 publication Critical patent/BR112014009266B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/05—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in nitriles (3.5.5)
    • C12Y305/05001—Nitrilase (3.5.5.1)

Abstract

resumo patente de invenção: "processo para a preparação de ácidos isoxazolil-metóxi-nicotínicos". a presente invenção refere-se a um processo para preparação de um composto de fórmula (i) que é útil como um intermediário na preparação de compostos farmacêuticos ativos de um composto de fórmula (iv) em que r1 e r2 são como definidos aqui.
BR112014009266-4A 2011-10-20 2012-10-17 Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos BR112014009266B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11185992.2 2011-10-20
EP11185992 2011-10-20
PCT/EP2012/070521 WO2013057123A1 (en) 2011-10-20 2012-10-17 Process for the preparation of isoxazolyl-methoxy-nicotinic acids

Publications (3)

Publication Number Publication Date
BR112014009266A2 true BR112014009266A2 (pt) 2017-06-13
BR112014009266A8 BR112014009266A8 (pt) 2020-04-22
BR112014009266B1 BR112014009266B1 (pt) 2021-05-04

Family

ID=47019026

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014009266-4A BR112014009266B1 (pt) 2011-10-20 2012-10-17 Processos encurtado, biocatalítico e para preparação de ácidos isoxazolil-metóxinicotínicos

Country Status (20)

Country Link
US (1) US8604062B2 (pt)
EP (1) EP2768827B1 (pt)
JP (1) JP5923174B2 (pt)
KR (2) KR102262697B1 (pt)
CN (1) CN103889978B (pt)
AR (1) AR088358A1 (pt)
AU (1) AU2012321095B2 (pt)
BR (1) BR112014009266B1 (pt)
CA (2) CA3112072C (pt)
DK (1) DK2768827T3 (pt)
ES (1) ES2613802T3 (pt)
HU (1) HUE031276T2 (pt)
IL (1) IL231645A (pt)
MX (1) MX2014004688A (pt)
MY (1) MY164880A (pt)
PL (1) PL2768827T3 (pt)
RU (1) RU2014118966A (pt)
SG (1) SG11201401626UA (pt)
SI (1) SI2768827T1 (pt)
WO (1) WO2013057123A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA202090521A1 (ru) * 2017-08-28 2020-06-10 Юниверсити Оф Мэриленд, Балтимор Новые модуляторы рецептора гамма-аминомасляной кислоты типа a против расстройств настроения
JP7478676B2 (ja) 2018-06-13 2024-05-07 エフ． ホフマン－ラ ロシュ アーゲー Ｇａｂａ ａ ａｌｐｈａ５ ｐａｍとしての新規イソオキサゾリルエーテル誘導体
HU231223B1 (hu) 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
JP7295667B2 (ja) 2019-03-20 2023-06-21 古河電気工業株式会社 保持具及び保護カバー
WO2021191837A1 (en) 2020-03-26 2021-09-30 Richter Gedeon Nyrt. 1,3-dihydro-2h-pyrrolo[3,4-c]pyridine derivatives as gabaa α5 receptor modulators

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2255294T3 (es) 1998-08-07 2006-06-16 Chiron Corporation Derivados de isoxazol sustituidos como moduladores del receptor de estrogenos.
US6551804B2 (en) * 1999-07-12 2003-04-22 E. I. Du Pont De Nemours And Company Process for preparing 4-cyanopentanoic acid
US20060148858A1 (en) 2002-05-24 2006-07-06 Tsuyoshi Maekawa 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
UA82292C2 (uk) * 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
AU2005245411B2 (en) 2004-05-14 2009-04-23 Irm Llc Compounds and compositions as PPAR modulators
PL1802566T3 (pl) 2004-10-01 2009-05-29 Hoffmann La Roche Podstawione heksafluoroizopropanolem pochodne eteru
ATE485269T1 (de) 2005-06-27 2010-11-15 Bristol Myers Squibb Co C-verknüpfte zyklische antagonisten des p2y1- rezeptors mit eignung bei der behandlung thrombotischer leiden
JP2009508905A (ja) 2005-09-19 2009-03-05 エフ．ホフマン−ラ ロシュ アーゲー ＧＡＢＡＡα５逆アゴニストとしてのイソオキサゾロ誘導体
JP2009511533A (ja) 2005-10-11 2009-03-19 エフ．ホフマン−ラ ロシュ アーゲー イソオキサゾール誘導体
ES2397401T3 (es) 2005-12-23 2013-03-06 F. Hoffmann-La Roche Ag Derivados de aril-isoxazol-4-il-oxadiazol
AU2008333326B2 (en) * 2007-12-04 2013-05-30 F. Hoffmann-La Roche Ag Isoxazolo-pyridine derivatives
AU2008333320B2 (en) 2007-12-04 2012-12-20 F. Hoffmann-La Roche Ag Isoxazolo-pyrazine derivatives
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
JP2012040448A (ja) * 2008-11-14 2012-03-01 Yasutaka Sakamoto マイクロバブル発生装置
US8222246B2 (en) 2009-04-02 2012-07-17 Hoffmann-La Roche Inc. Substituted isoxazoles
WO2010127978A1 (en) 2009-05-07 2010-11-11 F. Hoffmann-La Roche Ag Isoxazole-pyridine derivatives as gaba modulators

Also Published As

Publication number Publication date
HUE031276T2 (hu) 2017-07-28
SG11201401626UA (en) 2014-05-29
NZ622214A (en) 2016-08-26
AU2012321095A1 (en) 2013-05-09
MX2014004688A (es) 2014-05-28
BR112014009266B1 (pt) 2021-05-04
KR20140084209A (ko) 2014-07-04
BR112014009266A8 (pt) 2020-04-22
EP2768827A1 (en) 2014-08-27
DK2768827T3 (en) 2017-02-13
AR088358A1 (es) 2014-05-28
US8604062B2 (en) 2013-12-10
RU2014118966A (ru) 2015-11-27
PL2768827T3 (pl) 2017-05-31
CA2850440A1 (en) 2013-04-25
KR20200008671A (ko) 2020-01-28
SI2768827T1 (sl) 2017-04-26
CN103889978A (zh) 2014-06-25
CA2850440C (en) 2021-05-04
MY164880A (en) 2018-01-30
JP5923174B2 (ja) 2016-05-24
KR102262697B1 (ko) 2021-06-11
CN103889978B (zh) 2017-02-15
IL231645A0 (en) 2014-05-28
WO2013057123A1 (en) 2013-04-25
JP2014530831A (ja) 2014-11-20
CA3112072A1 (en) 2013-04-25
CA3112072C (en) 2023-06-13
IL231645A (en) 2016-09-29
ES2613802T3 (es) 2017-05-26
US20130102778A1 (en) 2013-04-25
AU2012321095B2 (en) 2015-08-20
EP2768827B1 (en) 2016-11-23

Similar Documents

Publication Publication Date Title
BR112014007193A2 (pt) derivados de pirazoloquinolinona, preparação dos mesmos e uso terapêutico dos mesmos
BR112012020983A2 (pt) processo para a preparação de derivados isoxazolina
BR112014010576A2 (pt) inibidores de neprilisina
BR112014004219A2 (pt) pirano[3,2-d][1,3]tiazol como inibidores de glicosidase
BR112012032244A2 (pt) processo para preparar derivados de antranilamida com tetrazole-substituído e polimorfos cristalinos novos e derivados destes
BR112013011580A2 (pt) derivados de ácido bisfenil pentanoico substituído por amino como inibidores de nep
BR112015009395A2 (pt) processo para preparação de derivados do ácido biliar
CR20140134A (es) Composiciones farmacéuticas
BR112013023517A2 (pt) "inibidores de produção de leucotrieno, seus usos, e composição farmacêutica"
CR20140301A (es) Derivados de betulina
BR112014003079A2 (pt) derivado de 1,2,3,4-tetra-hidroquinolina útil para o tratamento de diabetes
BR112013011593A2 (pt) cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo
BR112013031405A2 (pt) piridopirazinas substituídas como novos inibidores de syk
BR112013003439A2 (pt) "inibidores de oxadiazol de produção de leucotrieno"
BR112014006559A2 (pt) derivados do ácido betulínico com atividade antiviral
BR112014000471A2 (pt) processo para preparo de derivados de diamida de ácido antranílico substituídos com tetrazol por meio da reação de ácidos pirazóis com ésteres antranílicos
IN2014MN01521A (pt)
BR112014009266A2 (pt) processo para a preparação de ácidos isoxazolil-metóxi-nicotínicos
BRPI1014802B8 (pt) profármacos de triptolida.
BR112015012825A2 (pt) piridopirazinas substituídas como inibidores de syk
BR112013030145A2 (pt) processo para preparação de ácido metacrílico
BR112013030264A2 (pt) ácidos acéticos de benzociclohepteno
BR112014012459A2 (pt) 2h-indazóis como antagonistas do receptor de ep2
BR112014012458A2 (pt) processo para o preparo de derivados de esterol
BR112015002429A2 (pt) processo para a preparação de pemetrexede e sal de lisina do mesmo

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 17/10/2012, OBSERVADAS AS CONDICOES LEGAIS.